Guardian Pharmacy Services, Inc. (GRDN)

Market Cap	3.14B +58.5%
Revenue (ttm)	1.46B +4.9%
Net Income	74.77M +85.8%
EPS	1.17 +326.2%
Shares Out	63.35M
PE Ratio	42.24
Forward PE	33.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	339,071
Open	49.61
Previous Close	49.38
Day's Range	49.11 - 50.09
52-Week Range	26.34 - 50.59
Beta	0.05
Analysts	Strong Buy
Price Target	50.14 (+1.25%)
Earnings Date	Nov 5, 2026

About GRDN

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, tr...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 26, 2024
• Employees: 3,600
• Stock Exchange: NYSE
• Ticker Symbol: GRDN
• Website: https://guardianpharmacy.com

Analyst Summary

According to 7 analysts, the average rating for GRDN stock is "Strong Buy." The 12-month stock price target is $50.14, which is an increase of 1.25% from the latest price.

Price Target

$50.14

(1.25% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 14, 2026

Data Sources Report a data error